Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$27000.0.

  • Kestra Medical Technologies' Cash from Financing Activities rose 9530.43% to -$27000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $212.7 million, marking a year-over-year change of. This contributed to the annual value of $330.3 million for FY2025, which is 32491.09% up from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Cash from Financing Activities is -$27000.0, which was up 9530.43% from -$1.9 million recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Cash from Financing Activities registered a high of $214.7 million during Q2 2025, and its lowest value of -$1.9 million during Q3 2025.